Stockscreener 앱 받기
0.00
100.00%
-4.34
시간 외 거래:
4.35
4.35
+
Lumos Pharma Inc 주식(LUMO)의 최신 뉴스
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LUMO, ALTR, STAF on Behalf of Shareholders - The Eastern Progress Online
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MMLP and LUMO on Behalf of Shareholders - The Eastern Progress Online
Lumos Pharma Completes Merger and Delisting Process - TipRanks
Lumos Pharma and Double Point Ventures Announce Successful Completion of Tender Offer and Double Point Ventures' Acquisition of Lumos Pharma - The Manila Times
Lumos Pharma and Double Point Ventures Announce Successful Completion of Tender Offer and Double Point Ventures’ Acquisition of Lumos Pharma - Yahoo Finance
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LUMO, BMTX, NXU on Behalf of Shareholders - The Eastern Progress Online
Hepion Pharmaceuticals (NASDAQ:HEPA) Shares Down 4.1% – Here’s What Happened - Defense World
Lumos Pharma enters into definitive merger agreement with Double Point Ventures to go private via tender offer - substack.com
Global Human Growth Hormones Market to Reach USD 10 Billion by 2030 | DelveInsight - GlobeNewswire
Lumos Pharma Faces Uncertainty as CVRs Risk Expiring Worthless Post-Merger - MSN
LUMOLumos Pharma, Inc. Latest Stock News & Market Updates - StockTitan
Updated Phase 2 OraGrowtH Data Presented at ESPE 2024 - GlobeNewswire
Lumos Pharma reports sustained growth in PGHD trials - Investing.com
Biopharma deal value, down for year, surges 72% in October - BioWorld Online
Favourable Signals For Lumos Diagnostics Holdings: Numerous Insiders Acquired Stock - Yahoo Finance
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LUMO, PIK, OB on Behalf of Shareholders - GlobeNewswire
Private Advisor Group, LLC Acquires Shares in Lumos Pharma Inc - GuruFocus.com
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger of STAF, ATSG, GABC and ALTM - AccessWire
$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Reviews the Merger of STAF, ATSG, GABC and LUMO - AccessWire
$HAREHOLDER ALERT FOR STAF, ATSG, GABC and ALTM: The M&A Class Action Firm Continues to Investigate the Merger - AccessWire
Lumos: Q3 Earnings Snapshot - CT Insider
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LUMO, PIK, INSI on Behalf of Shareholders - GlobeNewswire
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Lumos Pharma Inc. – LUMO - GlobeNewswire Inc.
Peregrine Gold Ltd Confirms Prospectus Lodgement for Security Issue - MSN
Lumos Pharma Announces Two Abstracts Accepted for Oral Presentation at the 62ⁿᵈ Annual ESPE Meeting 2024 - The Manila Times
Finance Watch: Septerna Raises $288m In Public Market Debut - Citeline
Discover Smart Share Global Among 2 Other Prominent US Penny Stocks - Simply Wall St
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LUMO, ZUO, ARC on Behalf of Shareholders - Stockhouse Publishing
Analyst Expectations For Lumos Pharma's Future - Benzinga
INVESTIGATION ALERT: Halper Sadeh LLC Continues to - GlobeNewswire
Kuehn Law Encourages MMLP, ICCH, FSHP, and LUMO Investors to Contact Law Firm - Morningstar
DPV set to acquire Lumos Pharma for $38m - Pharmaceutical Technology
Lumos Pharma to be acquired by Double Point Ventures - Investing.com Canada
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Lumos Pharma, Inc. - Marketscreener.com
Jones Trading cuts Lumos Pharma shares rating amid Double Point merger - Investing.com UK
Lumos inks take-private deal with Double Point Ventures - MSN
LUMO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Lumos Pharma, Inc. Is Fair to Shareholders - Business Wire
Lumos Pharma Shares Rally After Double Point Deal - MarketWatch
Shareholder Alert: Ademi LLP Investigates Whether Lumos Pharma, Inc. Is Obtaining a Fair Price for Its Public Shareholders - The Bakersfield Californian
Lumos Pharma Enters into Definitive Merger Agreement with Double Point Ventures to Go Private via a Tender Offer of $4.25 Cash per Share Plus Contingent Value Rights (CVR) - The Manila Times
Lumos stock in focus after take-private deal (LUMO:NASDAQ) - Seeking Alpha
Double Point to Buy Lumos Pharma for $38M as FDA OKs Lumos Drug Trial - MarketWatch
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, USAP, SASR on Behalf of Shareholders - cnhinews.com
Gruve Acquires Lumos Cloud and Forms a Strategic Partnership with Gluware to Redefine AI-Powered Cloud and Network Automation - Yahoo Finance
Hypopituitarism Market Forecasted to Surge in Coming Years, - openPR
Lumos Pharma Inc (LUMO) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial Prudence - Investing.com Canada
0.60%
2.24%
자본화:
|
볼륨(24시간):